{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:00:45Z","timestamp":1791234045577,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27941-7","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:32:12Z","timestamp":1763548332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction and validation of gene signature for prognosis and drug sensitivity in cholangiocarcinoma based on cellular senescence related genes"],"prefix":"10.1038","volume":"15","author":[{"given":"Chao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"1","key":"27941_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley, P. J. et al. Cholangiocarcinoma. Nat. Rev. Disease Primers. 7 (1), 65 (2021).","journal-title":"Nat. Reviews Disease Primers"},{"issue":"2","key":"27941_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris, D. et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. Cancer J. Clin. 73 (2), 198\u2013222 (2023).","journal-title":"Cancer J. Clin."},{"issue":"9","key":"27941_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17 (9), 557\u2013588 (2020).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"issue":"1","key":"27941_CR4","doi-asserted-by":"publisher","first-page":"2310196","DOI":"10.1080\/07853890.2024.2310196","volume":"56","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Advances in targeted therapy of cholangiocarcinoma. Ann. Med. 56 (1), 2310196 (2024).","journal-title":"Ann. Med."},{"issue":"2","key":"27941_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cncr.34541","volume":"129","author":"KC Ohaegbulam","year":"2023","unstructured":"Ohaegbulam, K. C. et al. The multidisciplinary management of cholangiocarcinoma. Cancer 129 (2), 184\u2013214 (2023).","journal-title":"Cancer"},{"issue":"1","key":"27941_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","volume":"23","author":"G Spolverato","year":"2016","unstructured":"Spolverato, G. et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous Curative-Intent surgical resection. Ann. Surg. Oncol. 23 (1), 235\u2013243 (2016).","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"27941_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.32074\/1591-951X-252","volume":"113","author":"S Sarcognato","year":"2021","unstructured":"Sarcognato, S. et al. Cholangiocarcinoma. Pathologica 113 (3), 158\u2013169 (2021).","journal-title":"Pathologica"},{"issue":"6","key":"27941_CR8","first-page":"168","volume":"29","author":"R MJ","year":"2017","unstructured":", R. MJ Cellular senescence: What, Why, and how. Wounds: Compendium Clin. Res. Pract. 29 (6), 168\u2013174 (2017).","journal-title":"Wounds: Compendium Clin. Res. Pract."},{"issue":"3","key":"27941_CR9","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/v1030852","volume":"1","author":"P Merle","year":"2009","unstructured":"Merle, P. & Trepo, C. Molecular mechanisms underlying hepatocellular carcinoma. Viruses 1 (3), 852\u2013872 (2009).","journal-title":"Viruses"},{"issue":"7","key":"27941_CR10","doi-asserted-by":"publisher","first-page":"9874","DOI":"10.18632\/aging.202740","volume":"13","author":"D Guo","year":"2021","unstructured":"Guo, D. et al. DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress. Aging 13 (7), 9874\u20139899 (2021).","journal-title":"Aging"},{"issue":"6","key":"27941_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang, L., Lankhorst, L. & Bernards, R. Exploiting senescence for the treatment of cancer. Nat. Rev. Cancer. 22 (6), 340\u2013355 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"27941_CR12","doi-asserted-by":"crossref","unstructured":"Cai, X., Guillot, A. & Liu, H. Cellular senescence in hepatocellular carcinoma: the passenger or the driver? Cells 12(1). (2022).","DOI":"10.3390\/cells12010132"},{"issue":"2","key":"27941_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","volume":"99","author":"A Calcinotto","year":"2019","unstructured":"Calcinotto, A. et al. Cellular senescence: Aging, Cancer, and injury. Physiol. Rev. 99 (2), 1047\u20131078 (2019).","journal-title":"Physiol. Rev."},{"issue":"1","key":"27941_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13 (1), 816 (2022).","journal-title":"Nat. Commun."},{"issue":"7","key":"27941_CR15","doi-asserted-by":"publisher","first-page":"102897","DOI":"10.1016\/j.arcmed.2023.102897","volume":"54","author":"Z Li","year":"2023","unstructured":"Li, Z., Guo, M., Lin, W. & Huang, P. Machine Learning-Based integration develops a Macrophage-Related index for predicting prognosis and immunotherapy response in lung adenocarcinoma. Arch. Med. Res. 54 (7), 102897 (2023).","journal-title":"Arch. Med. Res."},{"issue":"W1","key":"27941_CR16","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48 (W1), W509\u2013w514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"27941_CR17","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"27941_CR18","doi-asserted-by":"crossref","unstructured":"Ma, D., Jiang, Y. Z., Liu, X. Y., Liu, Y. R. & Shao, Z. M. Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer. Breast Cancer Res. Treatment 2017, 162(1):39\u201348 .","DOI":"10.1007\/s10549-017-4113-z"},{"issue":"2","key":"27941_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184 (2), 404\u2013421e416 (2021).","journal-title":"Cell"},{"key":"27941_CR20","doi-asserted-by":"publisher","first-page":"698677","DOI":"10.3389\/fimmu.2021.698677","volume":"12","author":"A Lin","year":"2021","unstructured":"Lin, A. & Yan, W. H. HLA-G\/ILTs targeted solid cancer immunotherapy: opportunities and challenges. Front. Immunol. 12, 698677 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"27941_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu, J. et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12 (1), 21 (2020).","journal-title":"Genome Med."},{"key":"27941_CR22","doi-asserted-by":"crossref","unstructured":"Lin, A., Zhang, J. & Luo, P. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer. Frontiers in immunology 11:2039. (2020).","DOI":"10.3389\/fimmu.2020.02039"},{"key":"27941_CR23","doi-asserted-by":"crossref","unstructured":"Baumann, C., Zhang, X. & De La Fuente, R. Loss of CBX2 induces genome instability and senescence-associated chromosomal rearrangements. The J. cell. Biology 219 (11). (2020).","DOI":"10.1083\/jcb.201910149"},{"issue":"4","key":"27941_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/carcin\/bgad023","volume":"44","author":"C Gao","year":"2023","unstructured":"Gao, C. et al. MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial-mesenchymal transition. Carcinogenesis 44 (4), 279\u2013290 (2023).","journal-title":"Carcinogenesis"},{"issue":"12","key":"27941_CR25","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ajpath.2022.08.008","volume":"192","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. EZH2 promotes cholangiocarcinoma development and progression through histone methylation and microRNA-Mediated Down-Regulation of tumor suppressor genes. Am. J. Pathol. 192 (12), 1712\u20131724 (2022).","journal-title":"Am. J. Pathol."},{"key":"27941_CR26","doi-asserted-by":"publisher","first-page":"e11067","DOI":"10.7717\/peerj.11067","volume":"9","author":"P Sungwan","year":"2021","unstructured":"Sungwan, P. et al. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. PeerJ 9, e11067 (2021).","journal-title":"PeerJ"},{"issue":"1","key":"27941_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","volume":"13","author":"R Ruiz-Cordero","year":"2020","unstructured":"Ruiz-Cordero, R. & Devine, W. P. Targeted therapy and checkpoint immunotherapy in lung cancer. Surg. Pathol. Clin. 13 (1), 17\u201333 (2020).","journal-title":"Surg. Pathol. Clin."},{"issue":"24","key":"27941_CR28","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-19-0558","volume":"25","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer. Clin. Cancer Research: Official J. Am. Association Cancer Res. 25 (24), 7413\u20137423 (2019).","journal-title":"Clin. Cancer Research: Official J. Am. Association Cancer Res."},{"key":"27941_CR29","doi-asserted-by":"crossref","unstructured":"Seo, I. et al. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer. J. Immunother. Cancer 9(3). (2021).","DOI":"10.1136\/jitc-2020-001610"},{"issue":"6","key":"27941_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41388-018-0485-8","volume":"38","author":"YF Xu","year":"2019","unstructured":"Xu, Y. F. et al. HMGB1 correlates with angiogenesis and poor prognosis of Perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium. Oncogene 38 (6), 868\u2013880 (2019).","journal-title":"Oncogene"},{"issue":"7","key":"27941_CR31","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.7150\/ijbs.59068","volume":"17","author":"X Li","year":"2021","unstructured":"Li, X. et al. Aldolase A enhances intrahepatic cholangiocarcinoma proliferation and invasion through promoting Glycolysis. Int. J. Biol. Sci. 17 (7), 1782\u20131794 (2021).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"27941_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3892\/mco.2022.2499","volume":"16","author":"P Vanaroj","year":"2022","unstructured":"Vanaroj, P., Chaijaroenkul, W. & Na-Bangchang, K. Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review). Mol. Clin. Oncol. 16 (3), 66 (2022).","journal-title":"Mol. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27941-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27941-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27941-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:32:14Z","timestamp":1763548334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27941-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27941"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27941-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40661"}}